Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer

被引：0
|
作者：
Bashir Al Hussein Al Awamlh
Sam S. Chang
机构：
[1] Vanderbilt University Medical Center,Department of Urology
[2] A-1302 Medical Center Drive,undefined
[3] Vanderbilt Ingram Cancer Center,undefined
来源：
Current Oncology Reports | 2023年 / 25卷
关键词：
Non-muscle invasive bladder cancer; Intravesical chemotherapy; Carcinoma in situ of the bladder; BCG-unresponsive;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：83 / 91
页数：8
相关论文
共 50 条
  • [1] Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
    Al Awamlh, Bashir Al Hussein
    Chang, Sam S.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (02) : 83 - 91
  • [2] Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC)
    Werntz, Ryan P.
    Adamic, Brittany
    Steinberg, Gary D.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (10) : 2031 - 2040
  • [3] Emerging therapies in the management of high-risk non-muscle invasive bladder cancer (HRNMIBC)
    Ryan P. Werntz
    Brittany Adamic
    Gary D. Steinberg
    World Journal of Urology, 2019, 37 : 2031 - 2040
  • [4] Management of high-risk non-muscle invasive bladder cancer
    Brausi, M.
    Olaru, V.
    MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (04) : 255 - 260
  • [5] Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer
    Wiesen, Brett
    Hargis, Paige
    Flores, Hunter
    Kukreja, Janet
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [6] The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer
    Bola, Becky
    Hoskin, Peter J.
    Sangar, Vijay
    Choudhury, Ananya
    CANCERS, 2025, 17 (04)
  • [7] Genomic characterization of high-risk non-muscle invasive bladder cancer
    Meeks, Joshua J.
    Carneiro, Benedito A.
    Pai, Sachin G.
    Oberlin, Daniel T.
    Rademaker, Alfred
    Fedorchak, Kyle
    Balasubramanian, Sohail
    Elvin, Julia
    Beaubier, Nike
    Giles, Francis J.
    ONCOTARGET, 2016, 7 (46) : 75176 - 75184
  • [8] Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer
    Balar, Arjun, V
    Kamat, Ashish M.
    de Wit, Ronald
    LANCET ONCOLOGY, 2021, 22 (09): : E380 - E380
  • [9] THE OUTCOME OF PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER IN SWEDEN
    Wang, Eugen
    Larsson, Ulf
    Gardmark, Truls
    Malmstrom, Per-Uno
    JOURNAL OF UROLOGY, 2020, 203 : E1077 - E1077
  • [10] Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
    Zieger, Karsten
    Wiuf, Carsten
    Jensen, Klaus Moller-Ernst
    Orntoft, Torben Falck
    Dyrskjot, Lars
    BMC CANCER, 2009, 9
12345